While IL-27 supports EBV-transformed B-cell proliferation at doses secreted by infected cells in culture, we found that at high doses, IL-27 instead downmodulates EBNA expression, which might also provide anti-tumor effects by impairing transformed cell growth in vivo. The gene discussed is IL27; the disease is neoplasm.